{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T19:48:38Z","timestamp":1782503318078,"version":"3.54.5"},"reference-count":54,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Form Res"],"abstract":"\n Background<\/jats:title>\n Type 2 diabetes (T2D) is one of the most common noncommunicable diseases, requiring ongoing lifestyle changes and continuous glucose management through medication, diet, and physical activity. Traditional self-monitoring of blood glucose can be burdensome, especially with frequent finger pricks. As continuous glucose monitoring (CGM) becomes more affordable and accessible, it offers benefits such as increased glucose awareness, behavioral modifications, and reduced anxiety. However, challenges remain, including cost, discomfort, skin reactions, and privacy concerns. In the United Kingdom, perceptions of CGM among people with T2D, including both users and nonusers, are not well understood, limiting insight into factors influencing adoption and sustained use.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aims to explore how adults with T2D perceive the benefits and challenges of using CGM, including both current users and nonusers.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This study used a cross-sectional, online survey using YouGov\u2019s nationally representative panel to explore experiences of CGM among adults with T2D in the United Kingdom. A total of 531 participants were recruited from November to December 2024. Thematic analysis of responses to 2 open-ended questions identified key perceived benefits and challenges associated with CGM use.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 531 adults with T2D completed the YouGov online survey. Over half were male (297\/531, 55.9%) and aged 65 years and older (281\/531, 52.9%). Two-thirds (347\/531, 65.3%) had lived with T2D for more than 5 years, and 9.6% (51\/531) use or had previously used a CGM. Overall, 50.8% (270\/531) responded to at least one free-text question, with 49% (260\/531) commenting on benefits and 33.1% (176\/531) on challenges. Thematic analysis identified five key\u00a0benefit themes: (1) reduced monitoring burden, described as eliminating frequent finger prick testing and simplifying daily routines; (2) lifestyle feedback, enabling participants to better understand how diet and physical activity influence glucose levels; (3) greater control, by supporting more informed decision-making and increasing confidence in self-management; (4) feeling safer, through alerts for hypo- and hyperglycemia; and (5) sharing data with clinicians, which facilitated communication and more collaborative care. The main\u00a0challenges\u00a0were (1) access barriers, including restrictive eligibility criteria and the high cost of self-funding; (2) device issues, such as discomfort, inconvenience, and practical difficulties wearing the sensor; (3) technology reliance, with concerns about depending on devices rather than listening to bodily cues; (4) emotional strain, including anxiety, over-monitoring, and increased preoccupation with glucose levels; and (5) data concerns, particularly regarding accuracy, interpretation, and privacy.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Adults with T2D, including both users and nonusers, described CGM as a practical and empowering tool that improves understanding, safety, and collaboration with health care providers. Nevertheless, access barriers, usability issues, and emotional and data-related burdens remain major obstacles to equitable adoption. Addressing these through improved affordability, digital literacy support, and customized clinical guidance may support ongoing and inclusive CGM use in routine care.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/89898","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T19:05:09Z","timestamp":1776884709000},"page":"e89898","source":"Crossref","is-referenced-by-count":0,"title":["Perspectives on Continuous Glucose Monitoring Among Adults with Type 2 Diabetes in the United Kingdom: Cross-Sectional Survey"],"prefix":"10.2196","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1510-4294","authenticated-orcid":false,"given":"Albandari","family":"Alharbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6805-5241","authenticated-orcid":false,"given":"Elena","family":"Lammila-Escalera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2645-6191","authenticated-orcid":false,"given":"Benedict","family":"Hayhoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6975-3858","authenticated-orcid":false,"given":"Reham","family":"Aldakhil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2357-9858","authenticated-orcid":false,"given":"Azeem","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8772-4938","authenticated-orcid":false,"given":"Austen","family":"El-Osta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7107-7211","authenticated-orcid":false,"given":"Ana Luisa","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzaf046"},{"key":"ref3","unstructured":"One in five adults now live with diabetes or prediabetes in the UKDiabetes UK20252026-03-18https:\/\/www.diabetes.org.uk\/about-us\/news-and-views\/one-five-adults-now-live-diabetes-or-prediabetes-uk"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15326"},{"key":"ref5","unstructured":"Cost of devastating complications highlights urgent need to transform diabetes care in the UKDiabetes UK2026-03-18https:\/\/www.diabetes.org.uk\/about-us\/news-and-views\/cost-complications-highlights-urgent-need-transform-diabetes?"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0034"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2017.12.004"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-018-1186-z"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.599838"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2010.02573.x"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/193229681100500419"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/193229681000400631"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816628547"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39302.444572.DE"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5634"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad652"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.03.003"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2020.0666"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2023.04.001"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/26350106251326517"},{"key":"ref21","unstructured":"Can I get continuous glucose monitoring on the NHS?Diabetes UK2026-03-18https:\/\/www.diabetes.org.uk\/about-diabetes\/looking-after-diabetes\/technology\/continuous-glucose-monitors"},{"key":"ref22","unstructured":"A pan-London implementation document for continuous glucose sensors for people living with type 2 diabetesNHS England, NHS London Clinical Networks20252026-05-07https:\/\/www.england.nhs.uk\/london\/wp-content\/uploads\/sites\/8\/2025\/06\/A-pan-London-implementation-document-for-continuous-glucose-sensors-for-people-living-with-type-2-diabetes.pdf"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-021-01408-1"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/13645579.2020.1805550"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6.3.e34"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"ref27","unstructured":"YouGov2026-03-18https:\/\/corporate.yougov.com\/about\/"},{"key":"ref28","unstructured":"Research realityYouGov2026-03-18https:\/\/business.yougov.com\/product\/panel-methodology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2307\/249008"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2307\/30036540"},{"key":"ref31","author":"Bandura, A","year":"1986","journal-title":"Social Foundations of Thought and Action"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.22582\/am.v11i1.31"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-6-42"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2024.07.001"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2196\/73446"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1177\/19322968231183974"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-015-0620-7"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12820"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2022.108385"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-022-01229-9"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2013.0051"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51666"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/dme.70130"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15500"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1177\/109019818401100101"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-024-01403-9"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S466734"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1097\/CIN.0000000000000341"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-022-01469-w"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae125"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1177\/19322968221094831"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1177\/26350106221116899"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1177\/1357633X14533889"}],"container-title":["JMIR Formative Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/formative.jmir.org\/2026\/1\/e89898","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T19:35:08Z","timestamp":1782502508000},"score":1,"resource":{"primary":{"URL":"https:\/\/formative.jmir.org\/2026\/1\/e89898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":54,"URL":"https:\/\/doi.org\/10.2196\/89898","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.89898","asserted-by":"object"}]},"ISSN":["2561-326X"],"issn-type":[{"value":"2561-326X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}